Antiprotozoal Structure–Activity Relationships of Synthetic Leucinostatin Derivatives and Elucidation of their Mode of Action
Open Access
- 17 March 2021
- journal article
- research article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 60 (28) , 15613-15621
Abstract
Leucinostatin A is one of the most potent antiprotozoal compounds ever described, but little was known on structure–activity relationships (SAR). We used Trypanosoma brucei as a protozoal model organism to test synthetically modified derivatives, resulting in simplified but equally active compounds 2 (ZHAWOC6025) and 4 (ZHAWOC6027), which were subsequently modified in all regions of the molecule to gain an in‐depth SAR understanding. The antiprotozoal SAR matched SAR in phospholipid liposomes, where membrane integrity, leaking, and dynamics were studied. The mode of action is discussed based on a structure–activity analysis of derivatives in efficacy, ultrastructural studies in T. brucei, and artificial membrane models, mimicking membrane stability and membrane potential. The main site of antiprotozoal action of natural and synthetic leucinostatins lies in the destabilization of the inner mitochondrial membrane, as demonstrated by ultrastructural analysis, electron microscopy and mitochondrial staining. Long‐time sublethal exposure of T. brucei (200 passages) and siRNA screening of 12′000 mutants showed no signs of resistance development to the synthetic derivatives.Keywords
Funding Information
- Kommission für Technologie und Innovation (16445.1 PFLS-LS and 19208.1 PFPL-LS)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030_184662, 31003A_169355)
- Velux Stiftung (881)
- Innosuisse - Schweizerische Agentur für Innovationsförderung (34227.1 IP-LS)
This publication has 29 references indexed in Scilit:
- Isothermal Microcalorimetry, a New Tool to Monitor Drug Action against Trypanosoma brucei and Plasmodium falciparumPLOS Neglected Tropical Diseases, 2012
- Genome-wide RNAi screens in bloodstream form trypanosomes identify drug transportersMolecular and Biochemical Parasitology, 2011
- In vitro and in vivo antitrypanosomal activities of three peptide antibiotics: leucinostatin A and B, alamethicin I and tsushimycinThe Journal of Antibiotics, 2009
- Predicting and Tuning Physicochemical Properties in Lead Optimization: Amine BasicitiesChemMedChem, 2007
- Liposome-based formulations for the antibiotic nonapeptide Leucinostatin A: Fourier transform infrared spectroscopy characterization and in vivo toxicologic studyAAPS PharmSciTech, 2000
- A tightly regulated inducible expression system for conditional gene knock-outs and dominant-negative genetics in Trypanosoma bruceiMolecular and Biochemical Parasitology, 1999
- The nonapeptide leucinostatin A acts as a weak ionophore and as an immunosuppressant on T lymphocytesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1994
- Structural Elucidation of Minor Components of Peptidyl Antibiotic P168s (Leucinostatins) by Tandem Mass SpectrometryBioscience, Biotechnology, and Biochemistry, 1992
- The crystal and molecular structure of the α‐helical nonapeptide antibiotic leucinostatin ABiopolymers, 1989
- Structure of leucinostatin A, new peptide antibiotic from Paecilomyces lilacinus A-267Journal of the Chemical Society, Chemical Communications, 1982